What is Xtant Medical Holdings's liabilities held for sale?

Xtant Medical Holdings (XTNT) reported liabilities held for sale of $2.86M in Q4 2025.

What does liabilities held for sale mean?

Liabilities associated with disposal groups classified as held for sale, presented separately on the balance sheet.

Xtant Medical Holdings XTNT Liabilities held for sale

Liabilities held for sale at other companies

SSR MiningSSRM

$415.71M—

American Coastal Insurance CorporationACIC

$0-100%

ClearfieldCLFD

$0—

Acadia Realty TrustAKR

$161K—

AtkoreATKR

$21.2M—

Tetra TechTTEK

$0—

Other financials

Income statement

See full

Revenue$20.9M-36.5%

Gross profit$12.0M-40.9%

Operating income-$2.9M-375%

Net income-$3.1M-5,426%

EPS (diluted)-$0.02—

Balance sheet

See full

Cash & equivalents$12.2M+124%

Total debt$15.0M-34.9%

Total equity$48.6M+10.8%

Total assets$78.0M-18.6%

Cash flow

See full

Operating cash flow-$2.1M-265%

CapEx$194.0K-83.7%

Free cash flow-$2.3M-2,753%

Valuation

See full

Market cap$59.05M-32.5%

Enterprise value$61.89M-41.5%

P/E32.3×—

P/S0.5×-0.2×

Profitability

See full

Gross margin62.3%+4.2pp

Operating margin4.8%+2.8pp

Net margin1.5%+0.8pp

FCF margin6.4%+4.1pp

Returns & leverage

See full

Return on equity3.9%+2.1pp

Debt / equity0.3×-0.2×

Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation.

The official record: Xtant Medical Holdings’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's liabilities held for sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xtant Medical Holdings's liabilities held for sale?: Xtant Medical Holdings (XTNT) reported liabilities held for sale of $2.86M in Q4 2025.
What does liabilities held for sale mean?: Liabilities associated with disposal groups classified as held for sale, presented separately on the balance sheet.